Goldman Sachs’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
Other funds holding HELX
BFCFS
Goldman Sachs's HELX Position: Q3 2026 in Review
Goldman Sachs opened a new position in Franklin Genomic Advancements ETF (HELX) in Q3 2026: 7,321 shares worth $326K. The stake represents ﹤0.01% of the portfolio and ranks #5976 among its holdings.
11 funds tracked by Wall St. Rank hold HELX as of Q3 2026.
- Goldman Sachs held 7,321 shares of Franklin Genomic Advancements ETF worth $326K as of Q3 2026.
- Franklin Genomic Advancements ETF was a new Goldman Sachs position in Q3 2026.
- Franklin Genomic Advancements ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #5976 holding.
- 11 funds tracked by Wall St. Rank held Franklin Genomic Advancements ETF as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.